Unlocking the Future of Pharma: PEACCEL’s Breakthrough AI Platform for Biologics Wins French DeepTech Label.
29 February 2024
![](https://www.peaccel.com/wp-content/uploads/2024/02/20240229-peaccel-linkedin.png)
We are thrilled to announce that PEACCEL has been awarded the prestigious French DeepTech label by BPI France, the public investment bank dedicated to innovation. This recognition is a testament to our commitment to pushing the boundaries of biotechnology with our groundbreaking AI discovery platform for Biologics.
🔍 Our Platform’s Impact:
PEACCEL’s AI-driven platform is transforming the pharmaceutical industry by enabling access to previously inaccessible spaces for drug discovery. Our technology makes it possible to identify novel, life-changing drugs by replicating processes that occur in nature only 1% of the time. This opens up new horizons in the quest for groundbreaking treatments.
🏅 About the French DeepTech Label:
The DeepTech label from BPI France is reserved for companies that demonstrate strong growth potential and possess disruptive technologies. To be recognized, a company must innovate by overcoming technological barriers and present a significantly differentiating advantage over competitors.
For more information:
PEACCEL
Making the world disease free
Contact: AI-team@peaccel.com
http://www.peaccel.com/